Polycythemia hyperviscosity syndrome has been associated with multiple systemic effects. There is dearth of data on the effects of polycythemia on cardiac function. This case presents a newborn infant with symptomatic polycythemia in whom detailed myocardial function analysis for systolic and diastolic performance, as well as end-organ perfusion assessment was carried out using transthoracic echocardiography. Hemodynamic information in polycythemic infants before and after partial exchange could improve our understanding of the impact on myocardial performance.
Introduction
Polycythemia is a well-recognized phenomenon in the neonatal population with 3 to 5% of term neonates having a central hematocrit greater than 65%. 1 Neonatal hyperviscosity has been associated with the dysfunction of various organ systems. 2, 3 The relationship between hematocrit and viscosity is nearly linear below a hematocrit of 60%, but viscosity increases exponentially at a hematocrit of 70% or greater. 4, 5 The hyperviscosity syndrome is usually seen only in infants with venous hematocrits above 60%. Although low cardiac output and improvement after a partial exchange transfusion (PExT) have been reported in small number of infants, 6 there are no data on effects of polycythemia on diastolic function, superior vena caval and end-organ flows and their evolution after PExT. This information could facilitate greater understanding of the impact on cardiovascular physiology. Case A female infant was born at term by normal vaginal delivery and weighed 3030 g. Mother had diet-controlled gestational diabetes.
There was no history of delayed cord clamping at the time of delivery. She was noticed to be plethoric, tachypneic and lethargic 12 h after birth. Venous blood sample revealed a high hematocrit and hemoglobin of 73% and 267 g l À1 , respectively. In view of symptomatic polycythemia, an isovolumic PExT was performed with normal saline over 30 min, withdrawing blood from the radial artery and infusing saline intravenously through an infusion pump to maintain isovolemia. The volume of normal saline was calculated to reduce the hematocrit to 55%. Post-exchange venous hematocrit and hemoglobin were 51% and 181 g l À1 , respectively. Her clinical symptoms improved and she was discharged home after 2 days. Parental consent was obtained and the submission was exempt from formal review by the Institutions Ethics Board.
Echocardiographic analysis
Myocardial function and end-organ flows were assessed pre-and post-PExT and 24-h post-procedure using M-mode, two-dimensional, pulse-wave and color Doppler transthoracic echocardiography. For all Doppler evaluations, the angle between the ultrasound beam and the direction of blood flow was less than 151 and calculations were based on the average of three measurements.
Left ventricular output (LVO), mean velocity of circumferential fiber shortening, superior vena cava (SVC) flow and end systolic wall stress were assessed as described previously. [7] [8] [9] Diastolic performance was assessed by E and A wave from transmitral Dopplers using the apical four-chamber view. Isovolumic relaxation time was measured as the time between mitral valve closure and opening of the aortic valve. Pulmonary hemodynamics were assessed by calculating ratio of time to peak velocity/right ventricular ejection time and right ventricular output (RVO) from the pulmonary artery Doppler trace. Dopplers from the superior mesenteric artery and the anterior cerebral artery were imaged as described previously. 10, 11 Left anterior descending coronary artery was interrogated for flow measurements as described previously.
12 Table 1 summarizes various markers of cardiac function and end-organ flow. The effect on right ventricular hemodynamics was evident by an increase in right ventricular output and time to peak velocity/right ventricular ejection time. Left ventricular systolic functions (LVO and fractional shortening) showed a transient decline after exchange transfusion, whereas SVC flow showed mild changes. The diastolic function compromise was evident from altered E/A ratio ( Figure 1a ) and a prolonged isovolumic relaxation time. Coronary and other systemic artery curves followed the pattern of LV hemodynamics.
Discussion
Large-scale studies assessing cardiovascular changes occurring in neonatal polycythemia and their evolution with PExT are lacking, partly owing to diminishing patient population and recourse to other therapies such as increased fluid intake. This report elucidates the impact of polycythemia and PExT on global myocardial function and end-organ hemodynamics. Although PExT can lower the hematocrit, decrease viscosity and reverse many of the physiological abnormalities associated with polycythemia/hyperviscosity, it has not been shown to have a significant impact on the long-term outcomes. An increased incidence of neurological abnormalities and fine motor deficit at 2 years of age has been shown in untreated polycythemic infants. Fouron et al. 14 studied the cardiovascular effects of experimental polycythemia in newborn lambs using Fick's principle. Up to a hematocrit of 60 to 70%, a constant rise in respective resistances was observed. Swetnam and co-workers 6 studied the effects of PExT in 13 infants and noted an increase in cardiac index. The baseline studies in this series were repeated after treatment, or 12 to 24 h after observation.
Impact on systolic function Our study, although limited to one infant, depicts an initial low normal LVO and low SVC flow state, which showed a transient decline after PExT before recovering on subsequent assessments. Although a speculative explanation could be a slow hemodynamic adaptation of the systemic circulation, cardiovascular performance involves a complex interplay between preload, afterload and myocardial contractility. Polycythemia and the related hyperviscosity are likely to affect the afterload component by way of an increased systemic vascular resistance. A drop in afterload could manifest as a decline in isovolumic relaxation time and could have a favorable impact on LVO. The PExT was carried out as an isovolumic procedure, so this effect is unlikely to be owing to volumic changes.
SVC flow in newborn infants has been described as a novel marker of systemic blood flow with approximately 80% of this blood estimated to be returning from the brain. 9 Therefore, SVC blood flow is potentially a marker of cerebral blood flow with a significant correlation with LVO (r ¼ 0.63; P<0.0001). The SVC flow trend in this infant, although small in magnitude, mirrored that of LVO. Changes in SVC flow were modest and should not be interpreted as a major reduction/increase. An improvement in RVO has been a consistent finding. Although baseline values for time to peak velocity/right ventricular ejection time were within normal limits (>0.3), the pattern of increase in this time velocity relationship after PExT could possibly be owing to a decline in pulmonary vascular resistance.
Impact on diastolic function
The altered baseline markers of diastolic function (E/A ratio and isovolumic relaxation time) could be a manifestation of elevated LV-exposed vascular resistance and elevated afterload. Their evolution immediately after PExT and 24 h later suggests improvement in myocardial relaxation. Figure 1b depicts E/A ratio measurements immediately after PExT. Stress-velocity relationship (end systolic wall stress-mean velocity of circumferential fiber shortening) has been previously elucidated by Rowland and co-workers 8 while studying well term newborns aged 3 to 10 days. Our observations are similar to these authors and showed an increase in mean velocity of circumferential fiber shortening with declining end systolic wall stress, suggesting improvement in cardiac contractility coinciding with a decline in afterload.
Impact on end-organ blood flow Hyperviscosity in systemic circulation is likely to have an impact on end-organ blood flow. Restoration of cerebral blood flow velocity abnormalities after PExT has been shown previously. 15 Systemic artery assessments in our study closely mirrored changes in LVO, thereby underlining the importance of maintaining adequate cardiac output in such cases. The relationship of coronary flow and LVO and diastolic function is in agreement with work carried out previously. 12 Whether these low flow states can explain symptomatology and correlate with impact on long-term outcomes is still a subject of debate.
There is dearth of relevant data on the impact of polycythemia, and this information can greatly facilitate our understanding of its hemodynamic impact. Limitations of this study include report of a single case, the lack of information regarding atrial level shunting and the inadvertent omission of measurement of superior mesenteric artery Dopplers during the second assessment.
